The impact of the characteristics of extrahepatic organ failure (EHOF) including the onset time, number, type, and sequence on the prognosis of acute-on-chronic liver failure (ACLF) patients remains unknown.
Alto Neuroscience closes $45M round; Simcere partners with Connect; Myricx licenses WuXi antibody
Neuroscience company closes $45M round: Alto Neuroscience closed an oversubscribed $45 million Series C, led by InVivium Capital, it announced Tuesday. New investors included Franklin